Ryan Bethencourt

Ryan Bethencourt is a scientist, entrepreneur, and investor best known for his work as program director and venture partner at IndieBio. Ryan is one of the 21st century’s most prolific biotech investors and entrepreurs through his work funding and building over 70+ biotech companies over the last decade.

He was previously head of life sciences at the XPRIZE Foundation, the former CEO of Berkeley Biolabs and spent a decade developing human therapeutic with large companies like Pfizer, Merck, Amgen, Genentech. His work at the interface of science and business has been covered globally.

Ryan focuses on using biology as a technology to solve some of the world''s most intractable problems including the future of food, medicine, biological computation, consumer biotech and environmental challenges.

Some of the more notable and impactful companies Ryan has funded and helped build include,  Future of Food  (Ava Labs, New Wave Foods, Memphis Meats, Clara Foods, Geltor, Miraculex, Finless Foods, The NotCo, SugarLogix),  Medicine  (Orphidia,SyntheX, QIDNI labs, Neuroqore, Ravata, Venomyx Therapeutics, Scaled Biolabs, GEA enzymes, Mendel.ai, Bioaesthetics, Proteorex,Prellis Biologics, DNAlite, QuantumCyte),  Biological Computation  (Koniku, Catalog Technologies),  Consumer Biotech  (NERD Skincare, Amino labs, Mycoworks, Animal Biome),  Environmental  (Pembient, Bioinspira, UBA Biologics)

Ryan has a BSc degree in Biological Sciences (Molecular Genetics) from Warwick University, a joint Masters in Bioscience Enterprise (MBE) from Cambridge University and MIT. He''s also been a Doctor of Philosophy (PhD) Candidate at the Center for Regenerative Medicine at the University of Edinburgh before pivoting to build startups.

Expertise

• Biotechnology
• Future of Food
• Medicine
• Regenerative Medicine
• Bilogical Computation
• Digital Health
• Veterinary Medicine
• Start-ups
• Entrepreneurship
• Therapeutic Drug Development
• Emerging Markets
• Venture Capital